首页> JTO clinical and research reports> Successful Lorlatinib Rechallenge After Severe Drug-Induced Psychosis in ALK-Positive Metastatic NSCLC: A Case Report.

Successful Lorlatinib Rechallenge After Severe Drug-Induced Psychosis in ALK-Positive Metastatic NSCLC: A Case Report.

导出 LinkOut

翻译打印收藏纠错

第一作者： Alexius,John

第一单位： Royal Marsden Hospital, Lung Unit, London, United Kingdom.

作者： Alexius,John ^[1] ; Joanna,Vick ^[1] ; Sarah,Sarker ^[1] ; Elizabeth,Middleton ^[1] ; Elizabeth,Cartwright ^[1] ; Thubeena,Manickavasagar ^[1] ; David,McMahon ^[1] ; Nadza,Tokaca ^[1] ; Sanjay,Popat ^[2]

作者单位： Royal Marsden Hospital, Lung Unit, London, United Kingdom. ^[1] Royal Marsden Hospital, Lung Unit, London, United Kingdom.;Institute of Cancer Research, London, United Kingdom. ^[2]

关键词 ALK Adverse event Case report Lorlatinib Non–small cell lung cancer Psychosis

DOI 10.1016/j.jtocrr.2024.100689

PMID 39091593

发布时间 2024-08-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

JTO clinical and research reports

2024年5卷7期

100689页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

JTO clinical and research reports

2024年5卷7期

100689页

检索历史清除

Successful Lorlatinib Rechallenge After Severe Drug-Induced Psychosis in ALK-Positive Metastatic NSCLC: A Case Report.

JTO clinical and research reports

相似文献

同项目论文

JTO clinical and research reports

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Successful Lorlatinib Rechallenge After Severe Drug-Induced Psychosis in ALK-Positive Metastatic NSCLC: A Case Report.

JTO clinical and research reports

相似文献

同项目论文

JTO clinical and research reports

相关期刊

检索历史清除